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Complete Resection of an Isolated Chest Wall Metastasis
from Esophageal Carcinoma after Transhiatal
Esophagectomy and Gastric Pull-up at One and
a Half-Year Follow-Up
Joerg Lindenmann, MD, Veronika Matzi, MD, Christian Porubsky, MD, Alfred Maier, MD,
and Freyja-Maria Smolle-Juettner, MD
Introduction: In esophageal cancer, the liver, lung, and bones are the
most common sites of visceral metastases. Isolated chest wall metas-
tases are quite extraordinary and occur very rarely.
Methods: In February 2004, a 59-year-old male patient was admit-
ted with esophageal adenocarcinoma. Preoperative routine staging
failed to detect any metastases. A transhiatal esophagectomy and
retrosternal gastric pull-up with cervical esophago-gastrostomy were
performed. The definitive histopathological staging showed an ad-
enocarcinoma, Union Internationale Contre le Cancer stage I. The
first check-up 6 months later consisted of a computed tomographic
scan of the neck, thorax, and abdomen as well as endoscopy, and
raised no suspicion of distant metastases and/or local recurrence.
We detected an isolated subcutaneous tumor at the area of the
right ventrolateral chest wall 18 months after surgery. The magnetic
resonance tomography scan of the thorax showed a solid subcuta-
neous expansion. The surgical biopsy of this lesion confirmed the
suspicion of an isolated chest wall metastasis of the resected esoph-
ageal adenocarcinoma.
Results: A complete resection of the metastasis was performed
without any complications, and the chest wall deficiency became
stabilized using a Prolene-Mesh and could be closed directly by skin
and subcutaneous tissue.
Conclusions: In case of transhiatal esophageal resection without
operative participation of the chest wall, an isolated thoracic wall
metastasis can be explained by an occult widespread dissemination of
the tumor cells along the extensive esophageal lymphatic and hema-
togenous system. The final decision of surgical resection of this chest
wall metastasis should always be made by an interdisciplinary tumor
board.
Key Words: Esophagus, Esophageal cancer, Esophageal surgery,
Metastasectomy, Surgery.
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In esophageal cancer, the liver, lung, and bones are the mostcommon sites of hematogenic and/or lymphogenetic vis-
ceral metastases.1 Isolated chest wall metastases seem to be
very rare.
We describe the case of a 59-year-old man suffering
from esophageal adenocarcinoma who underwent transhiatal
esophagectomy and abdominal lymphadenectomy; the recon-
struction was performed by retrosternal gastric pull-up.
Eighteen months postoperatively, an isolated chest wall
metastasis of the esophageal carcinoma was detected and
could be resected successfully.
MATERIALS AND METHODS
In February 2004, a 59-year-old male patient was
admitted with the histopathologically proven diagnosis of
esophageal adenocarcinoma associated with the clinical
symptoms of high-grade dysphagia and weight loss of 10 kg
within 6 months. Routine staging was performed by using a
computerized tomography (CT) scan of the thorax and abdo-
men, ultrasonography, positron emission tomography (PET)
scan, esophago-gastro-duodenoscopy, and bronchoscopy.
Functional evaluation was performed by electrocardiogram
(ECG), cardiac ultrasonography, and spiroergometry.
The CT scan of the thorax and the mediastinum showed
a tumor of the distal esophagus. However, infiltration of the
trachea and the main bronchi could be excluded by bronchos-
copy. The CT scan of the abdomen and the abdominal
ultrasound showed no signs of tumor spread. The PET scan
demonstrated a pathological tracer uptake at the level of the
distal esophagus with no signs of distal metastases and/or
lymph node involvement. Esophago-gastro-duodenoscopy
showed a tumor stenosis 3 cm in length, from 37 to 40 cm,
and a diameter of 4 to 6 mm; in addition, there was an
intraluminal obstruction approximately more than 50% of
which was additionally confirmed by an esophagogram.
Endoscopic esophageal ultrasound (EUS) was not per-
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formed because of its absent influence on the further
scheduled procedure.
Transhiatal esophagectomy and two-field lymphade-
nectomy were carried out as reported in literature,2 and a total
of 27 lymph nodes were dissected. The stomach was tubu-
larized at the small curvature with resection of the gastro-
esophageal junction. The diameter of the interpositioned graft
was nearly 6 cm. Neither the right nor the left pleural space
had been opened during surgery. This was also documented
by the postoperative chest radiogram: there was no suspicion
of pleural effusion and/or pneumothorax. An intraoperative
frozen section showed no residual tumor at the proximal and
distal resection margins. The paraesophageal lymph nodes,
which were resectable by the transhiatal approach, appeared
slightly enlarged and macroscopically suspicious. Tumorous
infiltration of those lymph nodes could not be clearly ex-
cluded by intraoperative frozen section, so the decision was
made to place the gastric pull-up in the retrosternal location
if postoperative radiation would be required. The cervical
anastomosis was performed as a hand-sewn side-to-end cer-
vical esophago-gastrostomy. Further evaluation of the small
intestine and the complete abdominal cavity showed no signs
of metastases.
Final histopathological work-up of the specimens con-
firmed the diagnosis of an esophageal tubulopapillar adeno-
carcinoma with tumorous infiltration into the esophageal
submucosa without any nodular involvement. The definitive
staging was pT1 G2 pN0 pM0 pR0, corresponding to Union
Internationale Contre le Cancer stage I.
The further course of the patient was uneventful, and he
was discharged on the 14th postoperative day. As this was
stage I adenocarcinoma of the esophagus, adjuvant chemo-
therapy and/or radiation therapy was not offered to the
patient. However, a follow-up protocol was initiated with CT
scans and endoscopy every 6 months for the first year.
The first check-up 6 months later consisted of CT scan
of the neck, thorax, and abdomen and endoscopy and showed
no suspicion of distant metastases and/or local recurrence.
Eighteen months after esophagectomy, a painful sub-
cutaneous tumor was detected at the area of the right ventro-
lateral chest wall, below the inferior margin of the right
pectoral muscle. At the time of re-admission, the patient was
in a slightly poorer general condition: he reported massive
episodes of right-sided thoracic pain and unintentional weight
loss of 5 kg within the last 3 months. Although he obtained
morphine, relief from thoracic pain was not really significant.
The magnetic resonance tomography scan of the thorax
showed a 6  7  5-cm isolated solid expansion of the right
chest wall at the ventral side of the sixth rib with bulking of
the tumor toward the interpleural space (Figure 1). Neither
the lung, the diaphragm, nor the liver was infiltrated.
The surgical biopsy of this lesion with histopathologi-
cal work-up detected a metastasis from the esophageal ade-
nocarcinoma resected 18 months previously. Furthermore, a
CT scan of the neck, thorax, and abdomen and a PET scan
completed the preoperative staging. The PET scan demon-
strated a pathological tracer uptake of the chest wall
corresponding to the solitary esophageal metastasis with
no signs of distal tumor spread and no suspicion of any
bone metastases.
Functional reevaluation was done by electrocardiogram
(ECG), cardiac ultrasonography, and spiroergometry. Resec-
tion of the isolated chest wall metastasis was considered the
treatment of choice.
RESULTS
A complete resection of the chest wall metastasis was
performed with 5-cm macroscopic free resection margins
including partial resection of four ribs. The intraoperative
frozen section showed no residual tumor at the resection
margins. However, the definitive histological proven free
circumferential resection margins showed distances to the
tumor ranging from 1.5 cm to 2.5 cm. The defect of the
thoracic wall after resection was 13  12 cm. Partial resec-
tion of the sternum was not required, so the stability of the
right hemithoracic wall was not affected. The chest wall
defect was reconstructed using a Prolene-Mesh (Figure 2),
which was fixed with pericostal sutures. It was not necessary
to perform any additional pedicled muscle flaps for further
reconstruction. Skin and subcutaneous tissue could be fixed
on the Prolene-Mesh and closed directly.
Final histopathological work-up confirmed a metastasis
from the esophageal adenocarcinoma with infiltration of the
intercostal muscles and the rib bones resulting in partial rib
destruction. There was no residual tumor at the circumferen-
tial resection margins: neither the lateral, medial, cranial, or
caudal margins nor the parietal pleura was affected by the
tumor.
FIGURE 1. Magnetic resonance tomography scan of the
thorax: 6  7  5-cm isolated solid expansion of the right
chest wall at the ventral side of the sixth rib with bulking of
the tumor toward the interpleural space. There is no tumor-
ous infiltration of the lung or the gastric conduit.
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The complete resection of the chest wall metastasis
led to total relief of the thoracic pain; morphine was no
longer necessary. The further course of the patient was
uneventful, and he was discharged on the 7th postoperative
day (Figure 3).
As this was now stage IV adenocarcinoma of the
esophagus and because of complete resection, adjuvant che-
motherapy and/ or radiation therapy was not performed.
Moreover, the patient refused any form of further systemic
therapy or external radiation. However, a follow-up protocol
was initiated with PET scans and CT scans every 3 months
for the first year. Nearly 3 years after esophagectomy and 18
months after metastasectomy, there is no evidence of locore-
gional relapse, lymph node involvement, and/or further dis-
tant (re-)metastases.
DISCUSSION
In esophageal cancer, the liver, lung, and bones are the
most common sites of hematogenic and/or lymphogenetic
visceral metastases.1 The esophageal carcinoma is character-
ized by an extensive lymphatic dissemination via the longi-
tudinal lymphatic system along the esophagus, which drains
into a large number of widespread lymph nodes of the thorax
and the abdomen depending on the location of the tumor.2
The intraabdominal region can be reached via the vertebral
venous system.3 In the literature, some cases of metastatic
tumors of the intestinal tract from extraabdominal sites are
described,4,5 including metastases to the small intestine,6,7
which are quite extraordinary. Retrograde spread to the iliac,
mesenteric, and cervical lymph nodes was also found.8,9
Isolated chest wall metastases seem to be very rare; there
have been just a few cases reported in the literature to
date.10–12
This huge and widespread lymphatic and hematoge-
nous system connecting the esophagus with the intraabdomi-
nal region and the chest wall may be sufficient to explain why
this isolated chest wall metastasis could occur and could be
responsible for this extraordinarily bad prognosis in patients
with esophageal carcinoma caused by the occult widespread
dissemination of the tumor cells.
The most important factor for predicting lymph node
metastases in early esophageal cancer is the presence of
submucosal infiltration. Early adenocarcinomas and squa-
mous cell carcinomas do not differ with regard to their rate
of lymphatic involvement. The rate of lymph node metas-
tasis increases with the depth of submucosal infiltration,
but metastases can already occur in superficial submucosal
lesions.13
In recent literature, metastatic tumors in the ribs were
found mainly 14 months after esophageal resection.12 Neither
any neoadiuvant therapy nor adjuvant chemotherapy and/or
radiotherapy was successful, 11,12 and further bone metastases
appeared successively within the following 12 months.
Because of the high failure rate of any systemic therapy
associated with such an extraordinarily bad prognosis, the
right treatment of these bone metastases after esophageal
resection is unclear at this.
Operative resection of this chest wall metastasis was
discussed at an interdisciplinary tumor panel and was found
to be the treatment of choice for this patient. In this case,
resection treatment was absolutely indicated because of mas-
sive thoracic pain and to prevent further local disease
progression with infiltration of the lung, the diaphragm, the
liver, or the heart. Radiation therapy and/or chemotherapy
were discussed but not performed because one solitary
lesion with a diameter of 6  7  5 cm offers no chance
for complete remission compared with surgery. Moreover,
the patient refused any form of systemic therapy or exter-
nal radiation.
The reconstruction of the chest wall was performed
using a Prolene-Mesh for stabilization and direct closure of
the defect after mobilization of the subcutaneous tissue and
the skin. The option of using a local pedicled composite flap
or a free flap was not required because we could perform a
direct closure free of tension. Furthermore, a pedicled or free
flap also may have complications resulting in further morbid-
ity. Prolene-Mesh has been shown to provide sufficient sta-
bilization of the lateral chest wall because partial resection of
the sternum was not required. The stability of the right
FIGURE 2. Reconstruction of the chest wall defect using a
Prolene-Mesh, fixed with pericostal sutures and closed di-
rectly by mobilization of the skin and subcutaneous tissue.
FIGURE 3. The same patient 7 days after metastasectomy
and successful chest wall reconstruction.
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hemithorax had never been at risk, and the prevention of
paradoxical respiration was not demanded. Furthermore, the
use of a methyl-methacrylate-impregnated mesh is more
useful in stabilizing large sternal defects after major resec-
tions resulting in a higher risk of paradoxical respiration.14
Related to the loss of correct treatment of these bone
metastases, a follow-up protocol was initiated with PET scans
and CT scans every 3 months for the first year. Adjuvant
chemotherapy and/or radiation therapy was refused by the
patient because of his subjective postoperative well-being.
Nearly 3 years after esophagectomy and 18 months after
metastasectomy, there is no evidence of locoregional relapse
and/or further distant (re-)metastases.
Metastases of the chest wall after resection of an
esophageal carcinoma are usually considered to be implanta-
tion metastases resulting from the operation.15 In the present
case, the site of metastasis had not been affected during
surgery because the right pleural space had not been opened.
This was also documented by the postoperative chest radio-
gram; there was no suspicion of pleural effusion and/or
pneumothorax. Preoperative MRT scan, CT scan, and PET-
scan and intraoperative evaluation showed no signs of tumor
spread outside the reported chest wall lesion. The stomach
and the epipericardial adipose tissue revealed no sign of
tumorous infiltration. We could not find an argument for local
recurrence, which implicates tumor involvement of the retro-
sternal stomach and any other tissue surrounding the gastric
conduit. Furthermore, we found no suspicion of tumorous
infiltration affecting the parietal and/or visceral pleura.
This is why an isolated chest wall metastasis can be
explained by an occult widespread dissemination of the
tumor cells along the extensic esophageal lymphatic and
hematogenous system.
The final decision of surgical resection of this chest
wall metastasis should always be made in an interdisciplinary
tumor board consisting at least of surgeons, pathologists,
oncologists, and radiotherapists.
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